IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 66 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $650,000 | +87.9% | 307,987 | +98.7% | 0.06% | +156.5% |
| Q3 2017 | $346,000 | -24.9% | 155,027 | +12.6% | 0.02% | +21.1% |
| Q3 2015 | $461,000 | +436.0% | 137,700 | +491.1% | 0.02% | +533.3% |
| Q2 2015 | $86,000 | -80.4% | 23,297 | -80.3% | 0.00% | -83.3% |
| Q1 2015 | $438,000 | -77.2% | 118,000 | -86.0% | 0.02% | -75.7% |
| Q3 2014 | $1,923,000 | +7.6% | 839,923 | +36.2% | 0.07% | -3.9% |
| Q2 2014 | $1,788,000 | +2831.1% | 616,600 | +4010.7% | 0.08% | +2466.7% |
| Q1 2014 | $61,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |